Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia

Clinical trial NCT04948008 · UNKNOWN

Trial details

NCT number: NCT04948008
Sponsor: Shenzhen People's Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Familial Hypercholesterolemia - Homozygous Lipid Metabolism Disorders Proprotein Convertase Subtilisin/Kexin 9

Start date: 2019-11-05
Primary completion: 2020-07-15
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.